Prescription Weight Loss Pills Compared
Every prescription weight loss tablet compared on results, mechanism, side effects and restrictions, from orlistat and Q...
Evidence-based, medically reviewed articles on metabolic health, GLP-1 science, nutrition and sustainable weight management.
Every prescription weight loss tablet compared on results, mechanism, side effects and restrictions, from orlistat and Q...
The FDA approved semaglutide for MASH with fibrosis in August 2025 after the ESSENCE trial. Fatty liver is common in Sou...
Retatrutide targets three hormone receptors and produced 24.2 percent weight loss in phase 2 trials. Learn how it works,...
PCOS makes weight loss harder through insulin resistance, and weight gain makes PCOS worse. Here is how the cycle works...
Orforglipron was approved in April 2026 as a daily GLP-1 tablet with no food or water restrictions. Learn how it works,...
Blood pressure and lipids improve early during weight loss, often enough that existing medication needs reducing. Here i...
CagriSema combines semaglutide with cagrilintide, an amylin analogue targeting a separate fullness pathway. Learn how it...
Survodutide is a GLP-1 and glucagon dual agonist from Boehringer Ingelheim. Learn its phase 3 SYNCHRONIZE results, how i...
Constant mental preoccupation with food is what many people describe losing on GLP-1 medication, often valuing it more t...
Physician-authored articles on GLP-1, metabolism and sustainable fat loss, delivered to your inbox.
✓ Subscribed! Check your inbox.
No spam. Unsubscribe anytime.